Table 1.
Clinical characteristics and complications of COVID‐19 patients
| Characteristic | All patients (n = 304) | Myocardial injury | p value | |
|---|---|---|---|---|
| With (n = 96) | Without (n = 208) | |||
| Male (%) | 160 (52.6) | 61 (63.5) | 99 (47.6) | .010 |
| Age, median (IQR) | 65.0 (54.0–74.0) | 70.5 (60.1–79.0) | 62.0 (52.0–69.0) | <.001 |
| NCP types (%) | ||||
| Mild/common | 117 (38.5) | 22 (22.9) | 95 (45.7) | <.001 |
| Severe | 147 (48.4) | 49 (51.0) | 98 (47.1) | |
| Critically severe | 40 (13.2) | 25 (26.0) | 15 (7.2) | |
| Comorbidities (%) | 198 (65.1) | 76 (79.2) | 122 (58.7) | <.001 |
| Diabetes | 50 (16.4) | 17(17.7) | 33 (15.9) | .687 |
| Hypertension | 130 (42.8) | 52 (54.2) | 78 (37.5) | .006 |
| COPD | 21 (6.9) | 12 (12.5) | 9 (4.3) | .009 |
| Cardiovascular disease | 49 (16.1) | 27 (28.1) | 22 (10.6) | <.001 |
| Coronary artery disease | 32 (10.5) | 18 (18.8) | 14 (6.7) | .002 |
| Cerebrovascular disease | 21 (6.9) | 13 (13.5) | 8 (3.8) | .002 |
| Kidney disease | 12 (3.9) | 4 (4.2) | 8 (3.8) | 1 |
| Hepatic disease | 8 (2.6) | 3 (3.1) | 5 (2.4) | .711 |
| Cancer, auto‐immune disease | 32 (10.5) | 11 (11.5) | 21 (10.1) | .719 |
Note: p values are calculated by Student's t test, Mann–Whitney U test, or χ 2 test as appropriate. p values less than .05 was statistical significant (Boldface).
Abbreviations: COPD, chronic obstructive pulmonary disease; IQR, interquartile range; NCP, novel coronary pneumonia.